13F-HR filed by SUPERSTRING CAPITAL MANAGEMENT LP
SUPERSTRING CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 18:54:38 UTC, with 35 holding rows worth $199,517,915.
- Accession
- 0001931118-26-000011
- Filer
- CIK 1931118
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 35 entries on the cover page, a total value of $199,517,915 stated on the cover page (in dollars after the unit check, H1), rows summing to $199,517,915 with VALUE read as dollars as filed, 13F file number 028-23866. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 597,408 | $19,129,004 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 102,485 | $18,897,209 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 984,892 | $14,103,653 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 365,662 | $13,044,992 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 918,231 | $10,532,110 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 362,671 | $9,552,754 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 588,418 | $9,414,688 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 41,784 | $8,576,584 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 242,493 | $7,859,198 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 222,121 | $7,503,247 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 184,392 | $7,491,847 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 13,321 | $7,218,517 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 357,359 | $7,107,871 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 176,561 | $6,719,912 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 178,842 | $6,540,252 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 578,696 | $6,469,821 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 132,339 | $5,908,936 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,017,817 | $5,251,936 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 423,006 | $4,179,299 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 30,020 | $2,972,580 | dollars as filed | |
| GINKGO BIOWORKS HOLDINGS INC | 37611X209 | COMMON STOCK | 222,553 | $2,855,355 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 30,022 | $2,672,859 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 48,045 | $2,393,602 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 31,684 | $2,363,943 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 413,373 | $2,013,127 | dollars as filed | |
| Latigo Biotherapeutics, Inc. | 517954103 | Common Stock, par value $0.0001 per share | 88,178 | $1,472,573 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 15,446 | $1,286,497 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 118,304 | $1,205,518 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 2,099 | $1,057,812 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 517,412 | $993,431 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 26,496 | $985,386 | dollars as filed | |
| TONIX PHARMACEUTICALS HOLDIN | 890260839 | COMMON STOCK | 74,688 | $727,461 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 206,242 | $517,667 | dollars as filed | |
| GRAIL INC | 384747101 | COM | 3,238 | $453,709 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 225,872 | $44,565 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001931118-26-000011 | this filing | 2026-11-16 |